Pfizer New Diet Drug: Obsession for Healthy Change
Pfizer Inc., a renowned pharmaceutical company, has recently shared encouraging topline outcomes from their Phase 2b clinical trial. This...
PsychoGenics Revolutionary Brain Drug Set to Combat Mental Ills
PsychoGenics Inc., with its drug discovery platform PGI Drug Discovery LLC, has announced an exclusive license agreement with Roche...
JP Kotha Rises as VP of Bioanalytical at Worldwide Clinical Trials
Worldwide Clinical Trials, a significant contract research organization, has appointed Dr. Jayaprakash (JP) Kotha as Vice President, Bioanalytical. Dr....
Gilead Great Trodelvy Focus: New Insights
Gilead Sciences, Inc. is set to present new data at the San Antonio Breast Cancer Symposium (SABCS) 2023, highlighting...
AstraZeneca’s ASH 2023: Surging Hematology Innovations
At the upcoming 65th American Society of Hematology (ASH) Annual Meeting, AstraZeneca will present a wealth of new clinical...
DCTs are in Dire Need: Embrace Diversity Now
At the inaugural Black Women in Clinical Research conference, Dr. Jayne Morgan, an acclaimed cardiologist and health educator, delivered...
FDA on DCTs: Charting the Course for Innovative Trials
The 2023 Decentralized Trials & Research Alliance Summit (DTRA) marked a significant juncture in clinical research, particularly through its panel discussion...
DCTs: Washington’s Jubilant Journey To Revolutionize Trials
The 2023 Decentralized Trials & Research Alliance (DTRA) Annual Meeting featured a pivotal moment in clinical research with a...
Digital Therapeutic Clinical Trials: A Pioneering Approach to Better Treatments
In this engaging discussion, we delve into the dynamic and evolving world of digital therapeutic (DTx) and decentralized clinical...
Sunshine Act Compliance: A Better Empowerment for Life Science Companies
The origins of the Sunshine Act can be traced back to growing calls for transparency in healthcare and Life...